Panel Session: Over the Rainbow: How Emerging Companies Use Machine Learning as a Sustainable Competitive Advantage
Entrepreneurs have a zeal for promoting their AI capabilities. But are these capabilities adding meaningful healthcare value or are they simply high tech marketing tools? This panel will explore the strategic value of AI through the lens of both entrepreneurs and investors who will discuss:
- The business value of AI and machine learning technology
- Data ownership and transparency
- The risks and benefits of cloud computing platform
Jodi Hubler is the Managing Director of Lemhi Ventures, a health care services venture capital fund with $385M under management. Over her 25-plus-year career, she has held executive positions in a variety of public and private companies, including Cargill, Alcoa, and Definity Health, where she served as chief people officer. She has served as a board member or chair of the board in over a dozen health care services companies valued for her keen insight, direct approach, and skillful stewardship of organizations. She is especially adept at leading and governing in industries facing transformative change. Her experience across global organizations and multi-industry domains, coupled with her deep health care industry experience, make her uniquely qualified to provide insightful advice to boards and executive teams committed to creating significant value for stakeholders. In addition to currently serving on four privately held company boards, she is currently a member of the Healthcare Executives Leadership Network and Women Business Leaders in Health Care Foundation and serves on the University of Minnesota’s Discovery Capital Investment Advisory Board. Jodi also serves on the non-profit boards of Caring Bridge as Vice Chair and Medical Alley Association. Jodi holds undergraduate and graduate degrees from the University of Iowa.
Jon Pearce is co-founder and CEO of Zipnosis. As a healthcare entrepreneur with experience in med-tech start-ups and as a venture analyst, he is focused on leveraging the power of technology to improve the way health systems engage with and treat their patients.
Jack Schneeman is the current co-CEO at Phraze, a health tech company that uses its AI-driven digital medical scribe to give clinicians back the gift of time. Prior to Phraze, Jack worked in private equity as a senior associate at Northstar Capital and in investment banking as an analyst at Greene Holcomb & Fisher. He has an MBA from the University of Minnesota's Carlson School of Management and a BS from Santa Clara University. Jack is also a current member of the Minnesota Army National Guard and board member of the Minneapolis-St. Paul chapter of Singularity University. Jack is passionate about applying new technologies to help solve massive societal challenges.
Michael Finch, Ph.D., received his degree in Sociology from the University of Minnesota. Dr. Finch is known for his work on the cost, quality and financing of health care in the public and private market and is nationally recognized has as an expert in research methods and evaluation. From 1984 through 1998 he was a member of the faculty of the Division of Health Services Research and Policy at the University of Minnesota. From 1998 through 2004 Dr. Finch was Director of Research Programs for UnitedHealth Group. He currently serves as an Executive in Residence in the Medical Industry Leadership Institute in the Carlson School of Management and serves as Manger, design and analytics at Children’s Hospital and Clinics.
Dr. Finch’s community service includes Chair of the Board of the Minnesota Housing Finance Agency from 1995 through 2011 and a member and Chair of the Board of the Healthier Minnesota Community Clinic Fund Board from 2004-2008.